O

Oxford Sciences Innovation

62 employees

Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI & software, and deep tech.

Investor insights

Sectors invested in

Biotechnology40
Health Care30
Software21
Life Science19
Therapeutics18
Medical17
Artificial Intelligence16
Information Technology16
Machine Learning14
Electronics13
Pharmaceutical11
Manufacturing11
Quantum Computing10
Renewable Energy9
Medical Device9
Research8
Oncology8
Health Diagnostics8
Hardware8
Clinical Trials7

Funding rounds participated in

$9.9M sweet spot round size

Most of their 127 investments are in rounds between $3.4M and $28M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Life Sciences
Higher Education
Health Tech
Finance
Deep Tech
Asset Management
Business Development
Life Science
Venture Capital

Date founded

2015

Investments made

T

Theolytics raised $28M on August 25, 2023

Investors: University of Oxford, M Ventures, Epidarex Capital and Oxford Sciences Innovation

U

Undisclosed raised $121M on June 12, 2023

Investors: Syncona Limited and Oxford Sciences Innovation

C

Caristo Diagnostics raised $16M on April 17, 2023

Investors: Isis Enterprise of Isis Innovation Ltd., Oxford Investment Consultants LLP, LONGWALL VENTURE PARTNERS LLP and Oxford Sciences Innovation

M

Mixergy Ltd raised $11M on March 27, 2023

Investors: Williams Advanced Engineering, Kiko Ventures and Oxford Sciences Innovation

Q

QuantrolOx raised $3.7M on March 7, 2023

Investors: Serendipity Capital, Hoxton Ventures, 2xN, Voima Ventures and Oxford Sciences Innovation

Q

Quantum Motion Technologies raised $51M on February 21, 2023

Investors: Inkef, Robert Bosch Venture Capital GmbH (RBVC), IP Group plc, Parkwalk Advisors, Octopus Ventures, Porsche Automobil Holding SE, British Patient Capital and Oxford Sciences Innovation

A

Archangel Lightworks raised $4.3M on February 15, 2023

Investors: Silicon Roundabout and Oxford Sciences Innovation

G

Grey Wolf Therapeutics raised $49M on January 26, 2023

Investors: Earlybird Venture Capital, Canaan, British Patient Capital, Andera Partners and Oxford Sciences Innovation

A

Amber Therapeutics raised undisclosed on January 24, 2023

Investors: 8VC and Oxford Sciences Innovation

O

Oxford Ionics raised $36M on January 9, 2023

Investors: Braavos Investment Advisers, 2xN, Naspers Ventures, Lansdowne Partners, Torch Partners and Oxford Sciences Innovation

FAQ